FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

258702006: hour (qualifier value)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2002. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
384937015 hr en Synonym Active Entire term case sensitive SNOMED CT core module
384938013 h - hour en Synonym Active Entire term case sensitive SNOMED CT core module
384939017 hour en Synonym Active Entire term case sensitive SNOMED CT core module
650150010 hour (qualifier value) en Fully specified name Active Entire term case sensitive SNOMED CT core module
2620162015 hours en Synonym Active Entire term case sensitive SNOMED CT core module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
hour Is a Non-International System of Units unit of time true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely estradiol 2.083 microgram/1 hour and norethisterone acetate 10.417 microgram/1 hour prolonged-release transdermal patch Has concentration strength denominator unit True hour Inferred relationship Existential restriction modifier 1
Product containing precisely estradiol 2.083 microgram/1 hour and norethisterone acetate 10.417 microgram/1 hour prolonged-release transdermal patch Has concentration strength denominator unit True hour Inferred relationship Existential restriction modifier 2
Product containing precisely estradiol 3.125 microgram/1 hour prolonged-release transdermal patch Has concentration strength denominator unit True hour Inferred relationship Existential restriction modifier 1
Product containing precisely estradiol 1.042 microgram/1 hour prolonged-release transdermal patch Has concentration strength denominator unit True hour Inferred relationship Existential restriction modifier 1
Product containing precisely estradiol 1.563 microgram/1 hour prolonged-release transdermal patch Has concentration strength denominator unit True hour Inferred relationship Existential restriction modifier 1
Product containing precisely estradiol 1.667 microgram/1 hour prolonged-release transdermal patch Has concentration strength denominator unit True hour Inferred relationship Existential restriction modifier 1
Product containing precisely rotigotine 83.333 microgram/1 hour prolonged-release transdermal patch Has concentration strength denominator unit True hour Inferred relationship Existential restriction modifier 1
Product containing precisely estradiol 2.083 microgram/1 hour prolonged-release transdermal patch Has concentration strength denominator unit True hour Inferred relationship Existential restriction modifier 1
Product containing precisely estradiol 2.083 microgram/1 hour and norethisterone acetate 7.083 microgram/1 hour prolonged-release transdermal patch Has concentration strength denominator unit True hour Inferred relationship Existential restriction modifier 1
Product containing precisely estradiol 2.083 microgram/1 hour and norethisterone acetate 7.083 microgram/1 hour prolonged-release transdermal patch Has concentration strength denominator unit True hour Inferred relationship Existential restriction modifier 2
Product containing precisely estradiol 3.333 microgram/1 hour prolonged-release transdermal patch Has concentration strength denominator unit True hour Inferred relationship Existential restriction modifier 1
Product containing precisely estradiol 4.167 microgram/1 hour prolonged-release transdermal patch Has concentration strength denominator unit True hour Inferred relationship Existential restriction modifier 1
Product containing precisely scopolamine 13.889 microgram/1 hour prolonged-release transdermal patch Has concentration strength denominator unit True hour Inferred relationship Existential restriction modifier 1
Product containing precisely fentanyl 25 microgram/1 hour prolonged-release transdermal patch Has concentration strength denominator unit True hour Inferred relationship Existential restriction modifier 1
Product containing precisely testosterone 104.167 microgram/1 hour prolonged-release transdermal patch Has concentration strength denominator unit True hour Inferred relationship Existential restriction modifier 1
Product containing precisely buprenorphine 35 microgram/1 hour prolonged-release transdermal patch Has concentration strength denominator unit True hour Inferred relationship Existential restriction modifier 1
Product containing precisely fentanyl 50 microgram/1 hour prolonged-release transdermal patch Has concentration strength denominator unit True hour Inferred relationship Existential restriction modifier 1
Product containing precisely buprenorphine 52.5 microgram/1 hour prolonged-release transdermal patch Has concentration strength denominator unit True hour Inferred relationship Existential restriction modifier 1
Product containing precisely buprenorphine 70 microgram/1 hour prolonged-release transdermal patch Has concentration strength denominator unit True hour Inferred relationship Existential restriction modifier 1
Product containing precisely fentanyl 75 microgram/1 hour prolonged-release transdermal patch Has concentration strength denominator unit True hour Inferred relationship Existential restriction modifier 1
Product containing precisely fentanyl 100 microgram/1 hour prolonged-release transdermal patch Has concentration strength denominator unit True hour Inferred relationship Existential restriction modifier 1
Product containing precisely granisetron 129.167 microgram/1 hour prolonged-release transdermal patch Has concentration strength denominator unit True hour Inferred relationship Existential restriction modifier 1
Product containing precisely rotigotine 166.667 microgram/1 hour prolonged-release transdermal patch Has concentration strength denominator unit True hour Inferred relationship Existential restriction modifier 1
Product containing precisely glyceryl trinitrate 208.333 microgram/1 hour prolonged-release transdermal patch Has concentration strength denominator unit True hour Inferred relationship Existential restriction modifier 1
Product containing precisely testosterone 208.333 microgram/1 hour prolonged-release transdermal patch Has concentration strength denominator unit True hour Inferred relationship Existential restriction modifier 1
Product containing precisely testosterone 250 microgram/1 hour prolonged-release transdermal patch Has concentration strength denominator unit True hour Inferred relationship Existential restriction modifier 1
Product containing precisely nicotine 291.667 microgram/1 hour prolonged-release transdermal patch Has concentration strength denominator unit True hour Inferred relationship Existential restriction modifier 1
Product containing precisely nicotine 312.5 microgram/1 hour prolonged-release transdermal patch Has concentration strength denominator unit True hour Inferred relationship Existential restriction modifier 1
Product containing precisely glyceryl trinitrate 416.667 microgram/1 hour prolonged-release transdermal patch Has concentration strength denominator unit True hour Inferred relationship Existential restriction modifier 1
Product containing precisely nicotine 583.333 microgram/1 hour prolonged-release transdermal patch Has concentration strength denominator unit True hour Inferred relationship Existential restriction modifier 1
Product containing precisely glyceryl trinitrate 625 microgram/1 hour prolonged-release transdermal patch Has concentration strength denominator unit True hour Inferred relationship Existential restriction modifier 1
Product containing precisely nicotine 625 microgram/1 hour prolonged-release transdermal patch Has concentration strength denominator unit True hour Inferred relationship Existential restriction modifier 1
Product containing precisely rotigotine 250 microgram/1 hour prolonged-release transdermal patch Has concentration strength denominator unit True hour Inferred relationship Existential restriction modifier 1
Product containing precisely nicotine 875 microgram/1 hour prolonged-release transdermal patch Has concentration strength denominator unit True hour Inferred relationship Existential restriction modifier 1
Product containing precisely nicotine 937.5 microgram/1 hour prolonged-release transdermal patch Has concentration strength denominator unit True hour Inferred relationship Existential restriction modifier 1
Product containing precisely estradiol 312.5 nanogram/1 hour prolonged-release vaginal ring (clinical drug) Has concentration strength denominator unit True hour Inferred relationship Existential restriction modifier 1
Product containing precisely estradiol 2.083 microgram/1 hour prolonged-release vaginal ring (clinical drug) Has concentration strength denominator unit True hour Inferred relationship Existential restriction modifier 1
Product containing precisely estradiol 4.167 microgram/1 hour prolonged-release vaginal ring (clinical drug) Has concentration strength denominator unit True hour Inferred relationship Existential restriction modifier 1
Product containing precisely glyceryl trinitrate 400 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has concentration strength denominator unit True hour Inferred relationship Existential restriction modifier 1
Product containing precisely glyceryl trinitrate 600 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has concentration strength denominator unit True hour Inferred relationship Existential restriction modifier 1
Product containing precisely fentanyl 12 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has concentration strength denominator unit True hour Inferred relationship Existential restriction modifier 1
Product containing precisely glyceryl trinitrate 800 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has concentration strength denominator unit True hour Inferred relationship Existential restriction modifier 1
Product containing precisely buprenorphine 20 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has concentration strength denominator unit True hour Inferred relationship Existential restriction modifier 1
Product containing precisely buprenorphine 10 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has concentration strength denominator unit True hour Inferred relationship Existential restriction modifier 1
Product containing precisely glyceryl trinitrate 200 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has concentration strength denominator unit True hour Inferred relationship Existential restriction modifier 1
Product containing precisely glyceryl trinitrate 300 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has concentration strength denominator unit True hour Inferred relationship Existential restriction modifier 1
Product containing precisely estradiol 2.08 microgram/1 hour and norethisterone acetate 10.4 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has concentration strength denominator unit True hour Inferred relationship Existential restriction modifier 1
Product containing precisely estradiol 2.08 microgram/1 hour and norethisterone acetate 10.4 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has concentration strength denominator unit True hour Inferred relationship Existential restriction modifier 2
Product containing precisely estradiol 1.04 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has concentration strength denominator unit True hour Inferred relationship Existential restriction modifier 1
Product containing precisely estradiol 1.56 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has concentration strength denominator unit True hour Inferred relationship Existential restriction modifier 1
Product containing precisely estradiol 1.88 microgram/1 hour and levonorgestrel 625 nanogram/1 hour prolonged-release transdermal patch (clinical drug) Has concentration strength denominator unit True hour Inferred relationship Existential restriction modifier 2
Product containing precisely estradiol 1.88 microgram/1 hour and levonorgestrel 625 nanogram/1 hour prolonged-release transdermal patch (clinical drug) Has concentration strength denominator unit True hour Inferred relationship Existential restriction modifier 1
Product containing precisely estradiol 2.5 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has concentration strength denominator unit True hour Inferred relationship Existential restriction modifier 1
Product containing precisely estradiol 2.08 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has concentration strength denominator unit True hour Inferred relationship Existential restriction modifier 1
Product containing precisely ethinylestradiol 1.46 microgram/1 hour and norelgestromin 6.25 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has concentration strength denominator unit True hour Inferred relationship Existential restriction modifier 2
Product containing precisely ethinylestradiol 1.46 microgram/1 hour and norelgestromin 6.25 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has concentration strength denominator unit True hour Inferred relationship Existential restriction modifier 1
Product containing precisely estradiol 3.13 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has concentration strength denominator unit True hour Inferred relationship Existential restriction modifier 1
Product containing precisely estradiol 4.17 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has concentration strength denominator unit False hour Inferred relationship Existential restriction modifier 1
Product containing precisely selegiline 250 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has concentration strength denominator unit True hour Inferred relationship Existential restriction modifier 1
Product containing precisely estradiol 2.08 microgram/1 hour and norethisterone acetate 5.83 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has concentration strength denominator unit True hour Inferred relationship Existential restriction modifier 2
Product containing precisely estradiol 2.08 microgram/1 hour and norethisterone acetate 5.83 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has concentration strength denominator unit True hour Inferred relationship Existential restriction modifier 1
Product containing precisely estradiol 583 nanogram/1 hour prolonged-release transdermal patch (clinical drug) Has concentration strength denominator unit True hour Inferred relationship Existential restriction modifier 1
Product containing precisely selegiline 500 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has concentration strength denominator unit True hour Inferred relationship Existential restriction modifier 1
Product containing precisely oxybutynin 162 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has concentration strength denominator unit True hour Inferred relationship Existential restriction modifier 1
Product containing precisely selegiline 375 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has concentration strength denominator unit True hour Inferred relationship Existential restriction modifier 1
Product containing precisely nicotine 917 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has concentration strength denominator unit True hour Inferred relationship Existential restriction modifier 1
Product containing precisely nicotine 458 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has concentration strength denominator unit True hour Inferred relationship Existential restriction modifier 1
Product containing precisely rivastigmine 192 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has concentration strength denominator unit True hour Inferred relationship Existential restriction modifier 1
Product containing precisely rivastigmine 396 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has concentration strength denominator unit True hour Inferred relationship Existential restriction modifier 1
Product containing precisely levonorgestrel 833 nanogram/1 hour prolonged-release intrauterine drug delivery system (clinical drug) Has concentration strength denominator unit True hour Inferred relationship Existential restriction modifier 1
Product containing precisely progesterone 416.667 microgram/1 hour prolonged-release vaginal ring (clinical drug) Has concentration strength denominator unit True hour Inferred relationship Existential restriction modifier 1
Product containing precisely rotigotine 125 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has concentration strength denominator unit True hour Inferred relationship Existential restriction modifier 1
Product containing precisely rotigotine 41.667 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has concentration strength denominator unit True hour Inferred relationship Existential restriction modifier 1
Product containing precisely buprenorphine 5 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has concentration strength denominator unit True hour Inferred relationship Existential restriction modifier 1
Product containing precisely nicotine 1.563 milligram/1 hour prolonged-release transdermal patch (clinical drug) Has concentration strength denominator unit True hour Inferred relationship Existential restriction modifier 1
Product containing precisely buprenorphine 15 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has concentration strength denominator unit True hour Inferred relationship Existential restriction modifier 1

This concept is not in any reference sets

Back to Start